| Mr David Arthur Cowley, CRNA | |
|
140 Academy St, Presque Isle, ME 04769-3102 | |
| (207) 768-4315 | |
| (207) 768-4390 |
| Full Name | Mr David Arthur Cowley |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 140 Academy St, Presque Isle, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316962996 | NPI | - | NPPES |
| 1316962996 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RNA83248 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| A R Gould Hospital | Presque isle, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aroostook Medical Center | 1153233663 | 119 |
News Archive
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
Researchers in the UK have conducted a study showing that families and school staff support the use of coronavirus disease 2019 (COVID-19) mitigation measures in secondary schools as young people return to face-to-face education.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
The end of the 'sickie' could be in sight particularly for Brits. There are moves afoot in Britain to change what the health secretary Alan Johnson calls the sick-note culture.
A recent review paper published in the MDPI's journal Viruses highlights how available vaccines may be effective in protecting individuals against severe forms of coronavirus disease 2019 (COVID-19), but the protection against infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its transmission to others may be reduced – with consequences for community protection and herd immunity.
› Verified 8 days ago
| Entity Name | Aroostook Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396858999 PECOS PAC ID: 1153233663 Enrollment ID: O20031104000020 |
News Archive
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
Researchers in the UK have conducted a study showing that families and school staff support the use of coronavirus disease 2019 (COVID-19) mitigation measures in secondary schools as young people return to face-to-face education.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
The end of the 'sickie' could be in sight particularly for Brits. There are moves afoot in Britain to change what the health secretary Alan Johnson calls the sick-note culture.
A recent review paper published in the MDPI's journal Viruses highlights how available vaccines may be effective in protecting individuals against severe forms of coronavirus disease 2019 (COVID-19), but the protection against infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its transmission to others may be reduced – with consequences for community protection and herd immunity.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr David Arthur Cowley, CRNA 140 Academy St, Presque Isle, ME 04769-3102 Ph: (207) 768-4315 | Mr David Arthur Cowley, CRNA 140 Academy St, Presque Isle, ME 04769-3102 Ph: (207) 768-4315 |
News Archive
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
Researchers in the UK have conducted a study showing that families and school staff support the use of coronavirus disease 2019 (COVID-19) mitigation measures in secondary schools as young people return to face-to-face education.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
The end of the 'sickie' could be in sight particularly for Brits. There are moves afoot in Britain to change what the health secretary Alan Johnson calls the sick-note culture.
A recent review paper published in the MDPI's journal Viruses highlights how available vaccines may be effective in protecting individuals against severe forms of coronavirus disease 2019 (COVID-19), but the protection against infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its transmission to others may be reduced – with consequences for community protection and herd immunity.
› Verified 8 days ago
Richard H Tateishi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4315 Fax: 207-768-4390 | |
Mr. Robert G Mackinnon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000 | |
Mrs. Cathy L Chasse, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4314 | |
Mr. Jeffrey M Findlen, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4315 Fax: 207-768-4390 | |
Duane G Hart, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4000 Fax: 207-768-4390 | |
Laura J. Jordan, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4314 Fax: 207-768-4390 |